Many dialysis centres have no formal program for assessing and adjusting post-haemodialysis (HD) target weight. Apart from clinical assessment, there are bioimpedance devices and natriuretic peptides that could potentially aid clinical management. We wished to determine whether pre- or post-HD bioimpedance assessment of extracellular water (ECW) or N terminal probrain natriuretic peptide (NT-proBNP) affected patient outcomes.
Methods
Multi-frequency bioimpedance assessments (MFBIA) were made before and after the midweek dialysis session, along with a post-dialysis NT-proBNP measurement.
Results
Data from 362 patients, median age of 63 (50–76) years, 59.7% male, 41.2% Caucasoid, with a median dialysis vintage of 31.4 (13.5–61.7) months were available for review. During a median follow-up of 49.6 (21.9–50.2) months there were 110 (30.4%) deaths. Patients who died had significantly increased ECW, as % over-hydrated both pre-HD 6.6 (5.8–7.6)% vs. survivors 5.1 (4–6.6)%, and post-HD 5.1 (4–6.6)% vs. 0.5 (-1-2.2.0, p<0.001, respectively. They also had higher NT-proBNP 325 (122–791) vs. 102 (48–342) pmol/l, p = 0.002. Using an adjusted Cox model, pre-HD ECW overhydration remained an independent factor associated with mortality (overhydration %: hazard ratio 1.15, 95% limits 1.03–1.28, p = 0.013), with a receiver operator curve (ROC) value of 0.7.
Conclusions
ECW excess is associated with increased mortality for HD patients, with ECW excess pre-dialysis being the strongest association, although these patients also had increased ECW post dialysis. Future trials are required to determine whether achieving euvolaemia as determined by bioimpedance improves patient survival.
SteenkampR., RaoA., RoderickP.UK Renal Registry 17th Annual Report: Chapter 5 Survival and Cause of Death in UK Adult Patients on Renal Replacement Therapy in 2013: National and Centre-specific Analyses. Nephron.2015; 129(Suppl 1): 99–129.
3.
AriasE.United States Life Tables, 2011. National vital statistics reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics. National Vital Statistics System.2015; 64(11): 1–63.
4.
GBD 2013 Mortality, and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet.2015; 385(9963): 117–171.
5.
EknoyanG., BeckG.J., CheungA.K.; Haemodialysis (HAEMO) Study Group. Effect of dialysis dose and membrane flux in maintenance haemodialysis. N Engl J Med.2002; 347(25): 2010–2019.
6.
LocatelliF., Martin-MaloA., HannedoucheT..; Membrane Permeability Outcome (MPO) Study Group. Effect of membrane permeability on survival of haemodialysis patients. J Am Soc Nephrol.2009; 20(3): 645–654.
7.
FlytheJ.E., KshirsagarA.V., FalkR.J., BrunelliS.M.Associations of Posthaemodialysis Weights above and below Target Weight with All-Cause and Cardiovascular Mortality. Clin J Am Soc Nephrol.2015; 10(5): 808–816.
8.
DasguptaI., FarringtonK., DaviesS.J., DavenportA., MitraS.UK National Survey of Practice Patterns of Fluid Volume Management in Haemodialysis Patients: A Need for Evidence. Blood Purif.2016; 41(4): 324–331.
9.
DaviesS.J., DavenportA.The role of bioimpedance and biomarkers in helping to aid clinical decision-making of volume assessments in dialysis patients. Kidney Int.2014; 86(3): 489–496.
10.
WizemannV., WabelP., ChamneyP.. The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant.2009; 24(5): 1574–1579.
11.
NongnuchA., PanorchanK., DavenportA.Predialysis NTproBNP predicts magnitude of extracellular volume overload in haemodialysis patients. Am J Nephrol.2014; 40(3): 251–257.
12.
PaniaguaR., VenturaM.D., Avila-DíazM.. NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients. Nephrol Dial Transplant.2010; 25(2): 551–557.
13.
VernonK., PeasegoodJ., RiddellA., DavenportA.Dialyzers designed to increase internal filtration do not result in significantly increased platelet activation and thrombin generation. Nephron Clin Pract.2011; 117(4): c403–c408.
14.
DavenportA.Review article: Low-molecular-weight heparin as an alternative anticoagulant to unfractionated heparin for routine outpatient haemodialysis treatments. Nephrology (Carlton).2009; 14(5): 455–461.
15.
DaviesS.J., PhillipsL., NaishP.F., RussellG.I.Quantifying comorbidity in peritoneal dialysis patients and its relationship to other predictors of survival. Nephrol Dial Transplant.2002; 17(6): 1085–1092.
16.
FürstenbergA., DavenportA.Comparison of multifrequency bioelectrical impedance analysis and dual-energy X-ray absorptiometry assessments in outpatient haemodialysis patients. Am J Kidney Dis.2011; 57(1): 123–129.
17.
KumarS., KhosraviM., MassartA., PotluriM., DavenportA.Changes in upper limb extracellular water content during haemodialysis measured by multi-frequency bioimpedance. Int J Artif Organs.2013; 36(3): 203–207.
18.
KoningsC.J., KoomanJ.P., SchonckM.. Influence of fluid status on techniques used to assess body composition in peritoneal dialysis patients. Perit Dial Int.2003; 23(2): 184–190.
19.
KoningsC.J., KoomanJ.P., SchonckM.. Assessment of fluid status in peritoneal dialysis patients. Perit Dial Int.2002; 22(6): 683–692.
20.
ChamneyP.W., WabelP., MoisslU.M.. A whole-body model to distinguish excess fluid from the hydration of major body tissues. Am J Clin Nutr.2007; 85(1): 80–89.
21.
KyleU.G., BosaeusI., De LorenzoA.D.; ESPEN. Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr.2004; 23(6): 1430–1453.
22.
DavenportA.Changes in N-terminal pro-brain natriuretic peptide correlate with fluid volume changes assessed by bioimpedance in peritoneal dialysis patients. Am J Nephrol.2012; 36(4): 371–376.
23.
BoothJ., PinneyJ., DavenportA.N-terminal proBNP—marker of cardiac dysfunction, fluid overload, or malnutrition in haemodialysis patients?Clin J Am Soc Nephrol.2010; 5(6): 1036–1040.
24.
OatesT., PinneyJ.H., DavenportA.Haemodiafiltration versus high-flux haemodialysis: Effects on phosphate control and erythropoietin response. Am J Nephrol.2011; 33(1): 70–75.
25.
DavenportA., PetersS.A., BotsM.L.; HDF Pooling Project Investigators. Higher convection volume exchange with online haemodiafiltration is associated with survival advantage for dialysis patients: the effect of adjustment for body size. Kidney Int.2016; 89(1): 193–199.
26.
Kalantar-ZadehK., RegidorD.L., KovesdyC.P.. Fluid retention is associated with cardiovascular mortality in patients undergoing long-term haemodialysis. Circulation.2009; 119(5): 671–679.
27.
ChazotC., WabelP., ChamneyP., MoisslU., WieskottenS., WizemannV.Importance of normohydration for the long-term survival of haemodialysis patients. Nephrol Dial Transplant.2012; 27(6): 2404–2410.
28.
NongnuchA., CampbellN., SternE., El-KatebS., FuentesL., DavenportA.Increased postdialysis systolic blood pressure is associated with extracellular overhydration in haemodialysis outpatients. Kidney Int.2015; 87(2): 452–457.
29.
KumarS., KhosraviM., MassartA., PotluriM., DavenportA.Are serum to dialysate sodium gradient and segmental bioimpedance volumes associated with the fall in blood pressure with haemodialysis?Int J Artif Organs.2014; 37(1): 21–28.
30.
AgarwalR.B-type natriuretic peptide is not a volume marker among patients on haemodialysis. Nephrol Dial Transplant.2013; 28(12): 3082–3089.
31.
SivalingamM., VilarE., MathavakkannanS., FarringtonK.The role of natriuretic peptides in volume assessment and mortality prediction in Haemodialysis patients. BMC Nephrol.2015; 16: 218.
32.
SheenV., BhallaV., Tulua-TataA., BhallaM.A., WeissD., ChiuA., AbdeenO., MullaneyS., MaiselA.The use of B-type natriuretic peptide to assess volume status in patients with end-stage renal disease. Am Heart J.2007; 153(2): 244.e1–5
33.
SivalingamM., SureshM., FarringtonK.Comparison of B-type natriuretic peptide and NT proBNP as predictors of survival in patients on high-flux haemodialysis and haemodiafiltration. Haemodial Int.2011; 15(3): 359–365.
34.
KumarS., KhosraviM., MassartA., DavenportA.Is there a role for N-terminal probrain-type natriuretic peptide in determining volume status in haemodialysis patients?Nephron Clin Pract.2012; 122(1-2): 33–37.
35.
JacobsL.H., van de KerkhofJ.J., MingelsA.M.. Inflammation, overhydration and cardiac biomarkers in haemodialysis patients: a longitudinal study. Nephrol Dial Transplant.2010; 25(1): 243–248.
36.
NongnuchA., DavenportA.Skin autofluorescence advanced glycosylation end products as an independent predictor of mortality in high flux haemodialysis and haemodialysis patients. Nephrology (Carlton).2015; 20(11): 862–867.
37.
VerberneW.R., GeersA.B., JellemaW.T., VincentH.H., van DeldenJ.J., BosW.J.Comparative Survival among Older Adults with Advanced Kidney Disease Managed Conservatively Versus with Dialysis. Clin J Am Soc Nephrol.2016; 11(4): 633–640.
38.
RaimannJ.G., ZhuF., WangJ.. Comparison of fluid volume estimates in chronic haemodialysis patients by bioimpedance, direct isotopic, and dilution methods. Kidney Int.2014; 85(4): 898–908.
